DNZOF(DNZOF)
DNZOF
No analyst ratings available
No analyst price targets available for DNZOF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $7.95T | $8.14T | $8.42T | $8.57T | $8.92T |
| Low | $7.82T | $7.70T | $8.12T | $8.26T | $8.61T |
| High | $8.09T | $9.83T | $9.38T | $9.54T | $9.94T |
| EBITDA Avg | $965.50B | $989.34B | $1.02T | $1.04T | $1.08T |
| Low | $949.99B | $935.92B | $986.50B | $1.00T | $1.05T |
| High | $982.35B | $1.19T | $1.14T | $1.16T | $1.21T |
| EBIT Avg | $714.29B | $731.93B | $756.59B | $769.85B | $801.95B |
| Low | $702.82B | $692.40B | $729.83B | $742.62B | $773.58B |
| High | $726.76B | $883.69B | $842.93B | $857.70B | $893.46B |
| Net Income Avg | $440.16B | $508.00B | $564.23B | $585.32B | $659.73B |
| Low | $419.92B | $484.64B | $538.28B | $558.40B | $629.39B |
| High | $505.46B | $583.36B | $647.93B | $672.16B | $757.60B |
| EPS Avg | $161.64 | $186.56 | $207.21 | $214.95 | $242.28 |
| Low | $154.21 | $177.98 | $197.68 | $205.07 | $231.13 |
| High | $185.62 | $214.23 | $237.95 | $246.84 | $278.22 |
| Analysts (Rev / EPS) | 15 / 1 | 19 / 1 | 9 / 1 | 9 / 1 | 13 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $1.92T | $1.96T | $2.06T | $1.99T | $1.96T | $2.02T | $2.05T | $2.05T |
| Low | $1.90T | $1.92T | $2.02T | $1.95T | $1.93T | $1.98T | $2.02T | $2.01T |
| High | $1.94T | $2.01T | $2.09T | $2.02T | $1.99T | $2.05T | $2.09T | $2.08T |
| EBITDA Avg | $233.45B | $238.21B | $249.72B | $241.53B | $238.05B | $244.86B | $249.49B | $248.68B |
| Low | $230.72B | $232.93B | $245.48B | $237.43B | $234.01B | $240.70B | $245.25B | $244.46B |
| High | $235.23B | $243.62B | $253.53B | $245.21B | $241.68B | $248.59B | $253.29B | $252.47B |
| EBIT Avg | $172.71B | $176.23B | $184.75B | $178.69B | $176.11B | $181.15B | $184.57B | $183.98B |
| Low | $170.69B | $172.32B | $181.61B | $175.65B | $173.12B | $178.07B | $181.44B | $180.85B |
| High | $174.03B | $180.24B | $187.56B | $181.41B | $178.80B | $183.91B | $187.39B | $186.78B |
| Net Income Avg | $85.56B | $123.69B | $132.59B | $148.96B | $164.66B | $223.97B | $18.21B | $165.36B |
| Low | $83.67B | $120.96B | $129.66B | $145.67B | $161.03B | $219.02B | $17.81B | $161.71B |
| High | $87.26B | $126.14B | $135.22B | $151.91B | $167.92B | $228.41B | $18.57B | $168.64B |
| EPS Avg | $32.15 | $46.48 | $49.82 | $55.98 | $61.88 | $84.16 | $6.84 | $62.14 |
| Low | $31.44 | $45.45 | $48.72 | $54.74 | $60.51 | $82.30 | $6.69 | $60.77 |
| High | $32.79 | $47.40 | $50.81 | $57.09 | $63.10 | $85.83 | $6.98 | $63.37 |
| Analysts (Rev / EPS) | 5 / 1 | 5 / 1 | 4 / 1 | 4 / 1 | 4 / 1 | 4 / 1 | 3 / 1 | 3 / 1 |